Results 81 to 90 of about 1,168 (170)
Mìžnarodnij Endokrinologìčnij Žurnal, 2015 Background. In modern international guidelines, there are not distinguished criteria for the evaluation of clinical symptoms, including somatic, neurological status, although almost all neuroendocrinologists acknowledge the presence exactly of ...
O.O. Khyzhniak +2 more
doaj +1 more source
OBSTACLES IN MANAGING GIANT PROLACTINOMA
Journal of the ASEAN Federation of Endocrine SocietiesINTRODUCTION/BACKGROUNDSarcoidosis is a multisystem granulomatous inflammatory disorder with common involvement of the lungs, lymph nodes and heart. Neurosarcoidosis, especially hypothalamicpituitary involvement, is a rare phenomenon (<10% of sarcoidosis patients).
Siti Zakiah Ahmad Daud +4 more
openaire +1 more source
Rapid Visual Improvement After Cabergoline Therapy in a Macroprolactinoma Case
Endocrinology Research and Practice, 2018 Introduction: Medical therapy with dopamin agonists (DAs) is the first treatment of choice for prolactinomas. no matter how large or how severe the neurologic sequelae and cabergoline (CAB) is the best initial choice (1).
Elif Güneş +2 more
doaj +1 more source
Journal of Medical Case Reports, 2019 Background Prolactinomas are tumors of the pituitary gland that usually respond very well to treatment with cabergoline. Resistance to cabergoline is very rare, but when it occurs, it is a difficult problem to resolve if the tumor is inoperable.
Luiz Augusto Casulari +4 more
doaj +1 more source
Giant prolactinoma in a patient with germline SDHB mutation : case report and brief review [PDF]
, 2020 Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2020Fundamento: Os adenomas hipofisários podem ser de natureza esporádica ou hereditária.
Amaro, Edgar Antunes Alberto
core +2 more sources
Cabergoline monotherapy in GH- and PRL-cosecreting pituitary adenomas
Endocrine OncologyFunctional pituitary tumours, also called pituitary neuroendocrine tumours (PitNETs), typically produce a single hormone, based on the cell lineage from which they arise in the anterior pituitary.
James M McNeil +3 more
doaj +1 more source
Klinicheskiy sluchay gigantskoy prolaktin-sekretiruyushchey adenomy gipofiza u podrostka
Ожирение и метаболизм, 2010 Резюме. Пролактиномы редко выявляются у лиц детского возраста, но зачастую характеризуются более агрессивным ростом. И, несмотря на то, что подходы к лечению этих опухолей у взрослых хорошо изучены и в настоящее время предпочтение отдается ...
doaj +1 more source
Case report and literature review of pituitary apoplexy in a 14-year-old girl with prolactinoma
Discover MedicineBackground Pituitary adenomas are rare in pediatric populations, with prolactinomas representing 20–39% of childhood cases. Pituitary apoplexy-hemorrhage or infarction of a pituitary adenoma-occurs in only 2–12% of tumors and is exceedingly uncommon in ...
Xuewen Yuan +3 more
doaj +1 more source
(The) effect of bromocriptine treatment for invasive prolactinoma [PDF]
, 2004 의학과/석사[한글] 기능성 뇌하수체 선종 중 가장 빈도가 높은 프로락틴 분비선종의 경우 다른 선종에 비하여 크기가 크고 침습성인 경우가 많다. 프로락틴 분비선종의 치료방법으로는 수술적 치료 외에 도파민 항진제인 bromocriptine이 쓰이고 있으나 macroprolactinoma나 giant prolactinoma의 경우에는 아직 논란의 여지가 남아있다.
양문술
core
Prolactinoma gigante – 3 casos clínicos e revisão da literatura [PDF]
, 2016 ResumoOs prolactinomas gigantes são tumores raros, mais frequentes em homens, cujos critérios de diagnóstico incluem adenoma hipofisário com maior eixo igual ou superior a 4cm e extensão extrasselar, valor sérico de prolactina ≥1.000ng/mL e exclusão de ...
Resende, Mário +4 more
core +1 more source